Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,125
Total Claims
$920K
Drug Cost
570
Beneficiaries
$1,614
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+57%
Opioid rate vs peers
4.1% vs 2.6% avg
+51%
Cost per patient vs peers
$1,614 vs $1,068 avg
+46%
Brand preference vs peers
13.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.1%
Opioid Rate
451
Opioid Claims
$11K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,452 claims · $746K
Generic: 9,587 claims · $170K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 143 | $158K |
| Empagliflozin | 120 | $109K |
| Insulin Aspart | 39 | $52K |
| Apixaban | 64 | $49K |
| Insulin Degludec | 41 | $43K |
| Mirabegron | 43 | $28K |
| Rivaroxaban | 29 | $23K |
| Dulaglutide | 18 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $18K |
| Tirzepatide | 15 | $16K |
| Insulin Degludec | 26 | $16K |
| Insulin Detemir | 24 | $15K |
| Sitagliptin Phos/Metformin Hcl | 22 | $13K |
| Fluticasone/Vilanterol | 17 | $12K |
| Potassium Chloride | 204 | $10K |
Prescribing Profile
Patient Profile
72
Avg Age
72%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About